Furthermore, Corrales et al. [20] showed that testosterone therapy in men with hypogonadism is associated with the reduction or complete abrogation of spontaneous ex vivo production of IL-1β, IL-6 and TNF-α by antigen-presenting cells (APCs). The gene discussed is IL1B; the disease is hypogonadism.